Structural heterogeneity of terminal glycans in Campylobacter jejuni Lipooligosaccharides

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Semchenko, Evgeny A ^a   Day, Christopher J ^a   Moutin, Marc ^a   Wilson, Jennifer C ^a   Tiralongo, Joe ^a   Korolik, Victoria ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALO GM2; GANGLIOSIDE; GANGLIOTETRAOSYLCERAMIDE; GLYCAN; GLYCOCONJUGATE; GLYCOLIPID; LIPOOLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM COLONY; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CHICK; CJ1144 GENE; CJ1145 GENE; CONTROLLED STUDY; CST GENE; GENE CLUSTER; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; NONHUMAN; PREDICTION; WLAN GENE;

ANIMALS; BACTERIAL ADHESION; CACO-2 CELLS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHICKENS; CLUSTER ANALYSIS; GENES, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; LECTINS; LIPOPOLYSACCHARIDES; POLYSACCHARIDES; SEQUENCE ANALYSIS, DNA; SURFACE PLASMON RESONANCE;

ANIMALIA; CAMPYLOBACTER JEJUNI;

EID: 84864020068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040920     Document Type: Article

References (40)

1. Shahrizaila N, Yuki N, (2011) The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action. Expert Opin Pharmacother 12: 1551-1560.
2. Humphrey T, O'Brien S, Madsen M, (2007) Campylobacters as zoonotic pathogens: a food production perspective. Int J Food Microbiol 117: 237-257.
3. Blaser MJ, Berkowitz ID, LaForce FM, Cravens J, Reller LB, et al. (1979) Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med 91: 179-185.
4. Prendergast MM, Moran AP, (2000) Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. J Endotoxin Res 6: 341-359.
5. Nachamkin I, Allos BM, Ho T, (1998) Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev 11: 555-567.
6. Moran AP, Annuk H, Prendergast MM, (2005) Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. J Neuroimmunol 165: 179-185.
7. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, et al. (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci U S A 101: 11404-11409.
8. Heikema AP, Bergman MP, Richards H, Crocker PR, Gilbert M, et al. (2010) Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect Immun 78: 3237-3246.
9. Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, et al. (2010) TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol 185: 748-755.
10. Yuki N, (2010) Human gangliosides and bacterial lipo-oligosaccharides in the development of autoimmune neuropathies. Methods Mol Biol 600: 51-65.
11. Fujikawa K, Nakashima S, Konishi M, Fuse T, Komura N, et al. (2011) The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome. Chemistry 17: 5641-5651.
12. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, et al. (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665-668.
13. Gilbert M, Brisson JR, Karwaski MF, Michniewicz J, Cunningham AM, et al. (2000) Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-mhz (1)h and (13)c NMR analysis. J Biol Chem 275: 3896-3906.
14. Linton D, Gilbert M, Hitchen PG, Dell A, Morris HR, et al. (2000) Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. Mol Microbiol 37: 501-514.
15. Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, et al. (2002) The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem 277: 327-337.
16. Day CJ, Tiralongo J, Hartnell RD, Logue CA, Wilson JC, et al. (2009) Differential carbohydrate recognition by Campylobacter jejuni strain 11168: influences of temperature and growth conditions. PLoS One 4: e4927.
17. Semchenko EA, Day CJ, Wilson JC, Grice ID, Moran AP, et al. (2010) Temperature-dependent phenotypic variation of Campylobacter jejuni lipooligosaccharides. BMC Microbiol 10: 305.
18. Stintzi A, (2003) Gene expression profile of Campylobacter jejuni in response to growth temperature variation. J Bacteriol 185: 2009-2016.
19. Semchenko EA, Moutin M, Korolik V, Tiralongo J, Day CJ, (2011) Lectin array analysis of purified lipooligosaccharide: a method for the determination of molecular mimicry. Journal of Glycomics and Lipidomics 1: 5.
20. Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, et al. (2002) Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun 70: 787-793.
21. Louwen R, Heikema A, van Belkum A, Ott A, Gilbert M, et al. (2008) The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect Immun 76: 4431-4438.
22. Muller J, Meyer B, Hanel I, Hotzel H, (2007) Comparison of lipooligosaccharide biosynthesis genes of Campylobacter jejuni strains with varying abilities to colonize the chicken gut and to invade Caco-2 cells. J Med Microbiol 56: 1589-1594.
23. Fry BN, Feng S, Chen YY, Newell DG, Coloe PJ, et al. (2000) The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. Infect Immun 68: 2594-2601.
24. McSweegan E, Walker RI, (1986) Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates. Infect Immun 53: 141-148.
25. Houliston RS, Vinogradov E, Dzieciatkowska M, Li J, St Michael F, et al. (2011) Lipooligosaccharide of Campylobacter jejuni: similarity with multiple types of mammalian glycans beyond gangliosides. J Biol Chem 286: 12361-12370.
26. Hammerschmidt S, Muller A, Sillmann H, Muhlenhoff M, Borrow R, et al. (1996) Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 20: 1211-1220.
27. Holden N, Totsika M, Dixon L, Catherwood K, Gally DL, (2007) Regulation of P-fimbrial phase variation frequencies in Escherichia coli CFT073. Infect Immun 75: 3325-3334.
28. Weiser JN, Love JM, Moxon ER, (1989) The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell 59: 657-665.
29. Appelmelk BJ, Shiberu B, Trinks C, Tapsi N, Zheng PY, et al. (1998) Phase variation in Helicobacter pylori lipopolysaccharide. Infect Immun 66: 70-76.
30. van der Woude MW, Baumler AJ, (2004) Phase and antigenic variation in bacteria. Clin Microbiol Rev 17: 581-611.
31. Wilson DL, Rathinam VA, Qi W, Wick LM, Landgraf J, et al. (2010) Genetic diversity in Campylobacter jejuni is associated with differential colonization of broiler chickens and C57BL/6J IL10-deficient mice. Microbiology 156: 2046-2057.
32. Glover KJ, Weerapana E, Imperiali B, (2005) In vitro assembly of the undecaprenylpyrophosphate-linked heptasaccharide for prokaryotic N-linked glycosylation. Proc Natl Acad Sci U S A 102: 14255-14259.
33. Kowarik M, Young NM, Numao S, Schulz BL, Hug I, et al. (2006) Definition of the bacterial N-glycosylation site consensus sequence. EMBO J 25: 1957-1966.
34. Kanipes MI, Papp-Szabo E, Guerry P, Monteiro MA, (2006) Mutation of waaC, encoding heptosyltransferase I in Campylobacter jejuni 81-176, affects the structure of both lipooligosaccharide and capsular carbohydrate. J Bacteriol 188: 3273-3279.
35. Bernatchez S, Szymanski CM, Ishiyama N, Li J, Jarrell HC, et al. (2005) A single bifunctional UDP-GlcNAc/Glc 4-epimerase supports the synthesis of three cell surface glycoconjugates in Campylobacter jejuni. J Biol Chem 280: 4792-4802.
36. Hagiwara K, Collet-Cassart D, Kobayashi K, Vaerman JP, (1988) Jacalin: isolation, characterization, and influence of various factors on its interaction with human IgA1, as assessed by precipitation and latex agglutination. Mol Immunol 25: 69-83.
37. Lis H, Sharon N, (1987) Erythrina lectins. Methods Enzymol 138: 544-551.
38. Day CJ, Semchenko EA, Korolik V, (2012) Glycoconjugates play a key role in Campylobacter jejuni infection: interactions between host and pathogen. Front Cell Inf Microbio 2.
39. Hartley-Tassell LE, Shewell LK, Day CJ, Wilson JC, Sandhu R, et al. (2010) Identification and characterization of the aspartate chemosensory receptor of Campylobacter jejuni. Mol Microbiol 75: 710-730.
40. King RM, Day CJ, Hartley-Tassell LE, Connerton IF, Tiralongo J,et al. (Final revision) Carbohydrate binding and gene expression by in vitro and in vivo propagated Campylobacter jejuni after Immunomagnetic Separation. Journal of Basic Microbiology.